Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis

Published:2024-07 Issue: Volume:356 Page:753-762
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Calder Cameron N.,Kwan Angela T.H.,Teopiz Kayla M.,Wong Sabrina,Rosenblat Joshua D.,Mansur Rodrigo B.,Rhee Taeho Greg,Ho Roger,Cao Bing,McIntyre Roger S.

Publisher

Elsevier BV

Reference67 articles.

1. The revised CONSORT statement for reporting randomized trials: explanation and elaboration;Altman;Ann. Intern. Med.,2001

2. Ketamine versus ECT for non-psychotic treatment-resistant major depression;Anand;N. Engl. J. Med.,2023

3. Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: a comparative, randomized and double-blind study;Araújo-de-Freitas;Psychiatry Res.,2021

4. Antidepressants for treatment of depression in primary care: a systematic review and meta-analysis;Arroll;J. Prim. Health Care,2016

5. How to perform a meta-analysis with R: a practical tutorial;Balduzzi;Evid. Based Ment. Health,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis;Journal of Affective Disorders;2024-10

2. Rapid and long-lasting effects of subcutaneous esketamine on suicidality: An open-label study in patients with treatment-resistant depression;Journal of Psychiatric Research;2024-08

3. Esketamine in depression: putative biomarkers from clinical research;European Archives of Psychiatry and Clinical Neuroscience;2024-07-13